Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/01/2005US6960359 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
11/01/2005US6960358 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
11/01/2005US6960357 Controlled release; drugs mixed with inert ingredients compressed into tablets
11/01/2005US6960356 tablet or capsule comprising a drug such as ciprofloxacin, acyclovir, diltiazem, ranitidine, or captopril, a gas generator, a swelling agent, a viscolyzing agent, and optional gel forming polymer; Controlled Gas Powered System; stomach retention
11/01/2005US6960353 Formulations for the transdermal administration of fenoldopam
11/01/2005US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
11/01/2005US6960350 Comprises aliphatic/aromatic alcohol and aliphatic/aromatic aldehyde; synergism; for use in room, closet or shoe box
11/01/2005US6960346 Using citric acid esters or ethers
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005US6960341 Bifidobacteria and preparations containing them
11/01/2005US6960337 Methods and compositions for treating benign gynecological disorders
11/01/2005US6960300 Process for preparing water soluble diterpenes and their applications
11/01/2005US6960256 Formation of small crystals
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
11/01/2005CA2281496C New hydroxy derivatives of tylosin and process for their preparation
11/01/2005CA2264852C Use of methylphenidate or a pharmaceutically acceptable salt thereof
11/01/2005CA2193665C Benzimidazole derivatives for the treatment and prophylaxis of virus infections
11/01/2005CA2115792C Method for the treatment of pain
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/29/2005CA2564988A1 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
10/29/2005CA2503331A1 Lubricious ophthalmic solutions
10/29/2005CA2502992A1 Lubricious germicidal ophthalmic solutions
10/29/2005CA2501422A1 Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
10/28/2005WO2006126981A2 Compositions and methods for mucosal vaccination
10/28/2005WO2006124012A2 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
10/28/2005CA2565002A1 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
10/28/2005CA2564855A1 Compositions and methods for mucosal vaccination
10/27/2005WO2005101838A2 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005WO2005100581A1 Novel isochroman compound and use thereof in anticancer agent, etc.
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005100447A1 Peg-functional nucleic acid conjugate
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005100373A2 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
10/27/2005WO2005100370A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
10/27/2005WO2005100366A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
10/27/2005WO2005100365A1 Thienopyridine derivatives
10/27/2005WO2005100362A1 Liquid external preparation containing pranoprofen
10/27/2005WO2005100360A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
10/27/2005WO2005100357A1 Mitotic kinesin inhibitors
10/27/2005WO2005100356A1 Inhibitors of akt activity
10/27/2005WO2005100355A1 Cyclic amine compound
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100351A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
10/27/2005WO2005100350A1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100348A1 Amorphous ziprasidone hydrochloride
10/27/2005WO2005100347A1 Methods for minimizing thioamide impurities
10/27/2005WO2005100346A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100344A1 Inhibitors of akt activity
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005100340A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100337A1 Substituted dioxolane derivatives and their use of preparing the neuroregulator
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100331A2 Antidiabetic agents
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100324A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
10/27/2005WO2005100322A1 Sulphur-linked imidazole compounds for the treament of hiv
10/27/2005WO2005100316A1 Crystalline polymorph of a bazedoxifene acetate
10/27/2005WO2005100315A1 Bazedoxifene ascorbate as selective estrogen receptor modulator
10/27/2005WO2005099824A1 1-glyoxylamide indolizines for treating lung and ovarian cancer
10/27/2005WO2005099823A1 Therapeutic combination for treatment of alzheimers disease
10/27/2005WO2005099822A2 Reduction of drug / drug interactions with modafinil
10/27/2005WO2005099821A1 Use of simethicone in constipated patients
10/27/2005WO2005099776A2 Steroid sparing agents and methods of using same
10/27/2005WO2005099764A1 Antifungal composition for external use
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099758A2 Injectable bioartificial tissue matrix
10/27/2005WO2005099754A2 Maytansinoid analogs as antitumor agents
10/27/2005WO2005099747A1 Selective killing of cancer cells by induction of acetyltransferase via tnf-alpha and il-6
10/27/2005WO2005099740A1 Use of peptidic compounds for the prophylaxis and treatment of chronic headache
10/27/2005WO2005099737A1 Appetite-suppressing compositions and methods
10/27/2005WO2005099736A1 Antitumor remedy
10/27/2005WO2005099725A1 Preventive and/or remedy for inflammatory bowel diseases
10/27/2005WO2005099724A2 Functionalized water-soluble polyphosphazene and uses thereof as modifiers of biological agents
10/27/2005WO2005099723A1 Methods of treating hepatocellular carcinoma with denspm
10/27/2005WO2005099722A1 A composition containing beta-glucan for prevention and treatment of osteoporosis
10/27/2005WO2005099721A2 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
10/27/2005WO2005099720A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
10/27/2005WO2005099719A2 Methods and compositions for the treatment of respiratory syncytial virus
10/27/2005WO2005099718A1 Lung surfactant supplements
10/27/2005WO2005099717A1 Macular edema patient selection method and treatment with eye implant comprising a steroid
10/27/2005WO2005099716A2 Method for analyzing the biological age of a subject
10/27/2005WO2005099715A2 Treatment of ophthalmic conditions with mineralcorticoids
10/27/2005WO2005099714A1 Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
10/27/2005WO2005099713A2 Novel antiviral pharmaceutical composition
10/27/2005WO2005099712A2 Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
10/27/2005WO2005099711A1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2005WO2005099710A1 Substituted cinnolin-4-ylamines
10/27/2005WO2005099709A2 Bicyclic heterocycles useful as serine protease inhibitors
10/27/2005WO2005099708A1 Composition comprising itraconazole for oral administration
10/27/2005WO2005099707A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators
10/27/2005WO2005099706A2 Muscarinic acetylcholine receptor antagonists
10/27/2005WO2005099705A2 Preparation of imidazole derivatives and methods of use
10/27/2005WO2005099704A1 Methods for the treatment of hypertension
10/27/2005WO2005099703A1 Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism
10/27/2005WO2005099702A2 R(-)-11-hydroxyaporphine derivatives and uses thereof
10/27/2005WO2005099701A2 Methods of using sustained release aminopyridine compositions
10/27/2005WO2005099700A1 Methods for the treatment of hypertension
1 ... 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 4505 4506 ... 7860